Research Articles
Unleashing the Army Within: How a New Pill Could Revolutionize Cancer Fight
Discover how a new oral Cbl-b inhibitor pill could revolutionize cancer treatment by supercharging the body's immune system to fight tumors effectively.
The Hidden Battle Within: Decoding the Biology of Cancer Cachexia
Understanding cancer cachexia, the devastating metabolic syndrome responsible for a third of cancer deaths, and the latest research breakthroughs.
The Cell's Rogue Director: Uncovering a New Path to Cancer
Discover how the Rac1-YAP1 stability axis reveals a powerful new pathway that cancer cells exploit, opening exciting possibilities for future therapies.
Unleashing the Brakes: A New Weapon in the Fight Against Cancer
Discover how a new pan-Id protein antagonist shows remarkable promise in halting cancer growth by targeting previously 'undruggable' proteins.
The Cancer Survival Switch: How Low Oxygen Fuels a Treatment-Resistant Enemy Within
Scientists discover a hidden alliance between two cellular proteins that makes breast cancer tougher to beat.
The Guardian's Betrayal: When the Body's Cancer Defense Turns Rogue
Explore how mutations in the MDM2 protein can subvert the body's natural cancer defenses and contribute to tumor development.
The Hidden Battlefield: How Your Muscles Fight Cancer—And Sometimes Lose
Discover how immune cells in muscle tissue interact with cancer and contribute to muscle wasting in this engaging scientific exploration.
The Double Agent in Our Blood: Turning Cancer's Greatest Ally into its Worst Enemy
Discover how a new molecular glue therapy targets regulatory T-cells to enhance cancer immunotherapy effectiveness.
Unlocking a New Weapon Against Cancer: How Targeting the Cellular Protein Shredder p97 Could Revolutionize Therapy
Explore how targeting p97 protein homeostasis represents a groundbreaking approach to cancer therapy, focusing on CB-5083 inhibitor mechanism and clinical potential.
Helical Warriors: How Foldable Molecules Are Rewriting Cancer's Playbook
Discover how helical sulfonyl-γ-AApeptides target LC3 in cancer cells to disrupt autophagy and create new cancer therapies.